Newamsterdam Pharma Company Nv (NAMS)

Jun 14, 2026

NAMSW SEC FilingsNewAmsterdam Pha 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 14, 2026

Jun 12, 2026

NewAmsterdam Pharma Warrants (NAMSW) Plunge 11.78% as Sellers Dominate, Testing Key SupportVolume Weighted Price - newsline.com

Jun 12, 2026

Jun 11, 2026

NewAmsterdam Pharma Rises 3.17% as Shares Approach Resistance at $31.77Bollinger Band - newsline.com

Jun 11, 2026

Jun 11, 2026

A Look At NewAmsterdam Pharma (NAMS) Valuation After Recent Share Price Weakness - Yahoo Finance

Jun 11, 2026

Jun 10, 2026

(NAMSW) Risk Channels and Responsive Allocation - Stock Traders Daily

Jun 10, 2026

Jun 10, 2026

NewAmsterdam Pharma Company N.V.Ordinary Shares (NQ: NAMS - FinancialContent

Jun 10, 2026

Jun 10, 2026

EBIT of NewAmsterdam Pharma Company N.V. – BX:NAMS - TradingView

Jun 10, 2026

Jun 08, 2026

Billionaire Stanley Druckenmiller Likes This Small-Cap Pharma Stock in 2026 - Insider Monkey

Jun 08, 2026

Jun 06, 2026

All eyes on NewAmsterdam Pharma earnings as pipeline advances - Investing.com

Jun 06, 2026

Jun 05, 2026

Precision Trading with Newamsterdam Pharma Company N.v. (NAMS) Risk Zones - Stock Traders Daily

Jun 05, 2026

Jun 04, 2026

Capital World Investors holds 10.4% of NewAmsterdam Pharma (NAMS) - Stock Titan

Jun 04, 2026

Jun 03, 2026

5 Best Non-AI Stocks to Buy According to Billionaire Stanley Druckenmiller - Insider Monkey

Jun 03, 2026

Jun 03, 2026

NewAmsterdam Shareholders Approve ESPP and Governance Proposals - TipRanks

Jun 03, 2026

Jun 03, 2026

NewAmsterdam Pharma Announces Upcoming Presentations at the National Lipid Association (NLA) 2026 Scientific Sessions - The Manila Times

Jun 03, 2026

Jun 03, 2026

Oral cholesterol drug obicetrapib in multiple 2026 lipid meeting studies - Stock Titan

Jun 03, 2026

Jun 03, 2026

NewAmsterdam Pharma (NASDAQ: NAMS) shareholders back 2026 ESPP and extend share issuance powers - Stock Titan

Jun 03, 2026

May 30, 2026

(NAMSW) Movement as an Input in Quant Signal Sets - Stock Traders Daily

May 30, 2026

May 30, 2026

Debt to assets ratio of NewAmsterdam Pharma Company N.V. – BX:NAMS - TradingView

May 30, 2026

May 30, 2026

Inventory turnover of NewAmsterdam Pharma Company N.V. – BX:NAMS - TradingView

May 30, 2026

May 30, 2026

EBIT per share of NewAmsterdam Pharma Company N.V. – BX:NAMS - TradingView

May 30, 2026

May 29, 2026

Current ratio of NewAmsterdam Pharma Company N.V. – BX:NAMS - TradingView

May 29, 2026

May 29, 2026

Net income before discontinued operations of NewAmsterdam Pharma Company N.V. – BX:NAMS - TradingView

May 29, 2026

May 29, 2026

Taxes of NewAmsterdam Pharma Company N.V. – BX:NAMS - TradingView

May 29, 2026

May 29, 2026

NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in June - Sahm

May 29, 2026

May 28, 2026

NewAmsterdam Pharma Stock Rises as Fresh Filing Puts Its $4.3 Billion Drug Bet in Focus - Bez Kabli

May 28, 2026

May 27, 2026

NewAmsterdam Pharma (NAMS) CAO exercises options and sells 65,000 shares - Stock Titan

May 27, 2026

May 27, 2026

NewAmsterdam Pharma Warrants (NAMSW) Rally 3.05% as Price Nears Key ResistanceOvervalued Signals - thelegaladvocate.com

May 27, 2026

May 26, 2026

[144] NewAmsterdam Pharma Co N.V. SEC Filing - Stock Titan

May 26, 2026

May 26, 2026

NewAmsterdam Pharma (NAMS) Edges Higher as Shares Test Key Resistance LevelArms Index - The Legal Advocate

May 26, 2026

May 25, 2026

Technical Reactions to NAMS Trends in Macro Strategies - Stock Traders Daily

May 25, 2026

May 24, 2026

NewAmsterdam Pharma (NAMS) Q1 2026 Earnings: EPS Beat Reflects Cost Management Amid Pre-Revenue Phase - The Legal Advocate

May 24, 2026

May 22, 2026

NewAmsterdam Pharma Co NV (HAM:KH6) Cyclically Adjusted Pri - GuruFocus

May 22, 2026

May 22, 2026

NewAmsterdam Pharma (NAMS) Slightly Lower Amid Consolidation Near Key Support LevelsGamma Squeeze - newsline.com

May 22, 2026

May 18, 2026

NewAmsterdam Pharma Insiders Who Sold Avert US$477m Market Cap Dip - Moomoo

May 18, 2026

May 14, 2026

Bain Life Sciences trims NewAmsterdam (NAMS) holding to about 3.3% - Stock Titan

May 14, 2026

May 14, 2026

Trading the Move, Not the Narrative: (NAMS) Edition - Stock Traders Daily

May 14, 2026

May 14, 2026

Industry Analysts Just Made A Substantial Upgrade To Their NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Revenue Forecasts - Sahm

May 14, 2026

May 13, 2026

NewAmsterdam Pharma Company N.V. (NAMS) Eps Diluted (TTM) - Zacks Investment Research

May 13, 2026

May 12, 2026

NAMS: Interim PREVAIL results expected Q1 next year, with strong efficacy and broad market potential - TradingView

May 12, 2026

May 12, 2026

Piper Sandler reiterates NewAmsterdam Pharma stock rating at overweight By Investing.com - Investing.com Nigeria

May 12, 2026

May 12, 2026

TradingKey - TradingKey

May 12, 2026

May 12, 2026

Piper Sandler reiterates NewAmsterdam Pharma stock rating at overweight - Investing.com

May 12, 2026

May 12, 2026

HC Wainwright Has Negative Forecast for NAMS Q2 Earnings - MarketBeat

May 12, 2026

May 12, 2026

NewAmsterdam Pharma stock hits all-time high at 42.02 USD By Investing.com - Investing.com India

May 12, 2026

May 11, 2026

NAMS SEC FilingsNewAmsterdam Pharma Company N.V 10-K, 10-Q, 8-K Forms - Stock Titan

May 11, 2026

May 11, 2026

NewAmsterdam Pharma Company N.V. (NAMS) Discusses Clinical Development Update and Interim Analysis Plans for PREVAIL TrialSlideshow (NASDAQ:NAMS) 2026-05-11 - Seeking Alpha

May 11, 2026

May 11, 2026

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates - Yahoo Finance

May 11, 2026

May 11, 2026

Why NewAmsterdam Pharma (NAMS) Is Up 29.7% After Detailing Obicetrapib Phase 3 And Launch Milestones - simplywall.st

May 11, 2026

May 11, 2026

NewAmsterdam Pharma stock hits all-time high at 42.02 USD - Investing.com

May 11, 2026